banner
Pawg khoom
Tiv tauj peb

Hu rau:Errol Zhou (Mr.)

Tel: ntxiv 86-551-65523315

Mobile/WhatsApp: ntxiv 86 17705606359

QQ:196299583

Skype:lucytoday@hotmail.com

Email:sales@homesunshinepharma.com

Ntxiv:1002, Huanmao Tsev, No.105, Mengcheng Txoj kev, Hefei Lub zos, 230061 Tuam Tshoj

APIs thiab Intermediates
Tofacitinib Citrate CAS 477600-75-2

Tofacitinib Citrate CAS 477600-75-2

CAS TSIS TAU: 477600-75-2
Cov mis mos molecular: C16H20N6O
Molecular phaus: 312.37000
EINECS TSIS YOG: 689-145-4
MDL TSIS MUAJ: MFCD11035919

Txhawb tshuaj

Khoom Piav Qhia:

Khoom Lub Npe: Tofacitinib citrate CAS TSIS TAU: 477600-75-2

Lub ntsiab lus:

(3R, 4R) -4-methyl-3- (methyl-1H-pyrrolo [2,3-d] pyrimidin-4-ylamino) -β-oxo-1-piperidinepropanenitrile;

Tofacitinib;

Tasocitinib;

Tshuaj& Lub Cev Muaj Zog:

Tshwm sim: hmoov daj

Kev Ntsuas: ≥99.0%

Ceev: 1.296g/cm3

Kub Point: 585.845 ℃ ntawm 760 mmHg

Flash Point: 308.108 ℃

Refractive Index: 1.646

Vapor Siab: 0.0 ± 1.6 mmHg ntawm 25 ℃

Cov Ntaub Ntawv Kev Nyab Xeeb:

HS Code: 29335990

Lo Lus Teeb: Ceeb Toom

Cov Lus Qhia Teeb Meem: H315; H319; H335

Cov lus ceeb toom ceev faj:

P261; P264; P271; P280; P302+P352; P304+P340; P305+P351+P338; P312; P321; P332+P313; P337+P313; P362; P403+P233; P405; P501

CP-690550 yog pyrrolo [2,3-d] pyrimidine derivative, raws li Janus kinase inhibitor rau kev kho mob rheumatoid mob caj dab.

Lub npe tshuaj lom neeg ntawm Tofacitinib citrate yog 3-{(3R, 4R) -4-methyl-3-[methyl-(7H-pyrronozo [2,3-d] pyrimidine-4-yl) -piperidine-1-yl] -3-oxo-propionitrile citrate, Phau Ntawv Tshuaj yog Janus kinase inhibitor tsim los ntawm Pfizer (Asmeskas). Thaum lub Kaum Ib Hlis 6, 2012, Asmeskas Cov Khoom Noj thiab Tshuaj Yeeb Tshuaj (FDA) tau pom zoo cov tshuaj rau kev kho cov neeg laus nrog mob hnyav rau mob rheumatoid mob caj dab (RA) uas muaj lus teb tsis txaus lossis ua tsis zoo rau kev kho methotrexate. Tofatib tau qhia rau cov neeg laus uas muaj mob hnyav rau mob rheumatoid mob caj dab (RA) uas muaj lus tsis txaus lossis tsis txaus siab MTX cov lus teb thiab tuaj yeem siv ua ke nrog MTX lossis lwm yam tshuaj tua kab mob ua kom lub cev muaj zog (DMARDs).

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

Cov khoom lag luam nyob rau hauv patent tau muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm zaum kawg tshwj xeeb tshaj yog nrog tus neeg yuav khoom.


Cim npe nrov: tofacitinib citrate cas 477600-75-2, tuam ntxhab, cov chaw muag khoom, lub Hoobkas, yuav, hauv Tshuag

Xa kev nug